Vaidehi Trivedi
Pediatrics · Gastonia, NCNPI 1306284351
Payments from drug & device makers
Across 276 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$1K
- Gilead$730
- AbbVie$632
- Merck$446
- GSK$240
- Pfizer$208
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,856100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 65 | $1,062 |
| Gilead | 39 | $730 |
| AbbVie | 35 | $632 |
| Merck | 21 | $446 |
| GSK | 15 | $240 |
| Pfizer | 12 | $208 |
| Bayer | 12 | $183 |
| AstraZeneca | 8 | $183 |
| Novo Nordisk | 9 | $157 |
| Johnson & Johnson(2 entities) | 9 | $146 |
| Cranial Technologies, Inc | 7 | $117 |
| Boehringer Ingelheim | 7 | $107 |
| Sanofi Pasteur Inc. | 5 | $91 |
| Lilly USA, LLC | 5 | $85 |
| Abbott | 2 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $41 |
| Idorsia Pharmaceuticals US Inc | 2 | $40 |
| Ironshore Pharmaceuticals Inc. | 2 | $32 |
| Sobi, Inc | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Amgen | 2 | $28 |
| Tactile Systems Technology Inc | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $23 |
| Novartis | 1 | $22 |
| Seqirus USA Inc | 1 | $21 |
| Exact Sciences | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| OPKO Pharmaceuticals, LLC | 1 | $14 |
| VBI Vaccine (delaware) Inc. | 1 | $11 |
| Phathom Pharmaceuticals, Inc. | 2 | $9 |
How this compares
$4,856 in reported general payments places this provider in the 95th percentile of 1,818 pediatrics providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 11 | $50,727 |
| MounjaroTirzepatide | 21 | $31,968 |
| DescovyEmtricitabine/Tenofov Alafenam | 14 | $29,489 |
| IsentressRaltegravir Potassium | 14 | $26,656 |
| OzempicSemaglutide | 22 | $21,435 |
| EliquisApixaban | 16 | $17,623 |
| RybelsusSemaglutide | 12 | $11,047 |
| JardianceEmpagliflozin | 17 | $10,848 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $1,819 |
| Gabapentin | 42 | $1,249 |
| Naproxen | 14 | $1,218 |
| Fluticasone Propionate | 25 | $864 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $775 |
| Tizanidine Hcl | 62 | $773 |
| Atorvastatin Calcium | 90 | $753 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $157 | $32,48334 claims |
| Lilly USA, LLCMounjaro | $85 | $31,96821 claims |
| GileadDescovy | $730 | $29,48914 claims |
| MerckIsentress | $446 | $26,65614 claims |
| PfizerEliquis | $208 | $17,62316 claims |
| Boehringer IngelheimJardiance | $107 | $10,84817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,818 pediatrics providers in North Carolina.
Other pediatrics in Gastonia
- Richard BrugmanGastonia$73K
- Priya KishnaniDurham$20.3M
- Dwight KoeberlDurham$9.2M
- Emmanuel WalterDurham$8M
- Joseph MuenzerChapel Hill$5.9M
- Edward SmithDurham$2.8M
- Christine TurleyCharlotte$1.5M
- Maria EscolarChapel Hill$1.3M
- Rasheed GbadegesinDurham$1M
- David KatzWake Forest$671K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.